AR001070A1 - Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación - Google Patents

Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación

Info

Publication number
AR001070A1
AR001070A1 AR33502496A AR33502496A AR001070A1 AR 001070 A1 AR001070 A1 AR 001070A1 AR 33502496 A AR33502496 A AR 33502496A AR 33502496 A AR33502496 A AR 33502496A AR 001070 A1 AR001070 A1 AR 001070A1
Authority
AR
Argentina
Prior art keywords
methyl
application form
pyrrolidenyl
isoxazole
suitable salts
Prior art date
Application number
AR33502496A
Other languages
English (en)
Inventor
Franke Hanshermann
Gerd Hoffmann
Heinrich Kindel
Stepehen P Arneric
James P Sullivan
John B Cannon
Original Assignee
L T S Lohmann Therapie Systeme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L T S Lohmann Therapie Systeme filed Critical L T S Lohmann Therapie Systeme
Publication of AR001070A1 publication Critical patent/AR001070A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Una forma de aplicación para el sumistro de (s)-3-metil-5-(1-metil)-2- pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas estácaracterizada porque se presenta como sistema terapéutico trasdermal en forma de emplasto.
AR33502496A 1995-01-14 1996-01-12 Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación AR001070A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501022A DE19501022C1 (de) 1995-01-14 1995-01-14 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
AR001070A1 true AR001070A1 (es) 1997-09-24

Family

ID=7751534

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33502496A AR001070A1 (es) 1995-01-14 1996-01-12 Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación

Country Status (12)

Country Link
EP (1) EP0802790B1 (es)
JP (1) JPH10511972A (es)
KR (1) KR19980701419A (es)
AR (1) AR001070A1 (es)
AT (1) ATE292458T1 (es)
BR (1) BR9607488A (es)
CA (1) CA2210341A1 (es)
DE (2) DE19501022C1 (es)
IL (1) IL116615A (es)
NZ (1) NZ298428A (es)
WO (1) WO1996021434A1 (es)
ZA (1) ZA96260B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
DE10118282A1 (de) 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100525B (pt) * 1991-05-29 1999-10-29 Abbott Lab Azaspiranos substituidos imunomodulares, seu uso e composicoes farmaceuticas que os contem
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device

Also Published As

Publication number Publication date
IL116615A0 (en) 1996-03-31
ZA96260B (en) 1996-08-01
EP0802790B1 (de) 2005-04-06
KR19980701419A (ko) 1998-05-15
DE59611212D1 (de) 2005-05-12
JPH10511972A (ja) 1998-11-17
ATE292458T1 (de) 2005-04-15
EP0802790A1 (de) 1997-10-29
BR9607488A (pt) 1997-12-23
IL116615A (en) 1999-09-22
CA2210341A1 (en) 1996-07-18
NZ298428A (en) 1999-10-28
MX9705324A (es) 1997-10-31
DE19501022C1 (de) 1996-06-05
WO1996021434A1 (de) 1996-07-18

Similar Documents

Publication Publication Date Title
DE69622780D1 (de) Transdermales therapeutisches System mit kontrollierter Wirkstofffreisetzung
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
DK0949925T3 (da) Flad lægemiddelform til anbringelse i mundhulen med frigivelse der af buprenorphin eller et farmakologisk sammenligneligt stof, samt fremgangsmåde til fremstilling deraf
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
ES2056660T3 (es) Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.
EE04006B1 (et) Transkorneaalne seade ravimite kontrollitavaks manustamiseks
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
GR960100179A (el) Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα.
NO974808L (no) Styrt frigivelse av legemidler for miose og mydriase i fremre kammer
DE69704712D1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
AR001070A1 (es) Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
SE9102181D0 (sv) Anordning foer aastadkommande av permanent foerbindelse mellan bukvaegg och bukhaala

Legal Events

Date Code Title Description
FB Suspension of granting procedure